Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Youji Shoukei"'
Autor:
Yutaro Ohno, Eri Okita, Mika Kawai-Uchida, Youji Shoukei, Kazuhiro Soshiroda, Tomoyuki Kanda, Shinichi Uchida
Publikováno v:
Journal of Pharmacological Sciences, Vol 152, Iss 3, Pp 193-199 (2023)
The adenosine A2A receptor antagonist/inverse agonist, KW-6356 has been shown to be effective in Parkinson's disease (PD) patients as monotherapy and as an adjunct therapy to L-3,4-dihydroxyphenylalanine (L-DOPA)/decarboxylase inhibitor. However, the
Externí odkaz:
https://doaj.org/article/c813e07e2733429a92c3bfbdfcba0ff4
Autor:
Takehisa Kawata, Shin Tokunaga, Miki Murai, Nami Masuda, Waka Haruyama, Youji Shoukei, Yutaka Hisada, Tetsuya Yanagida, Hiroshi Miyazaki, Michihito Wada, Tadao Akizawa, Masafumi Fukagawa
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195316 (2018)
Cinacalcet hydrochloride (cinacalcet), an oral calcimimetic agent has been widely used for the management of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD). In sharp contrast to vitamin D receptor activators, cinacalcet suppress
Externí odkaz:
https://doaj.org/article/ac2d2caae5b94be0b3ff292f83e53552
Autor:
Yutaro Ohno, Eri Okita, Mika Kawai-Uchida, Naoko Fukuda, Youji Shoukei, Kazuhiro Soshiroda, Koji Yamada, Tomoyuki Kanda, Shinichi Uchida
Publikováno v:
European Journal of Pharmacology. 950:175773
Autor:
Masafumi Fukagawa, Takehisa Kawata, Yutaka Hisada, Tadao Akizawa, Tetsuya Yanagida, Michihito Wada, Miki Murai, Nami Masuda, Waka Haruyama, Youji Shoukei, Hiroshi Miyazaki, Shin Tokunaga
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195316 (2018)
PLoS ONE
PLoS ONE
Cinacalcet hydrochloride (cinacalcet), an oral calcimimetic agent has been widely used for the management of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD). In sharp contrast to vitamin D receptor activators, cinacalcet suppress